The Experience of Initiating Oral Adjuvant Treatment for Estrogen Receptor–Positive Breast Cancer

Jane Flanagan, PhD, RN, ANP-BC; Devin Tetler, MS, RN, AGPCNP-BC; Loren Winters, MSN, ANP-BC, OCN®; Kathryn Post, MS, APRN-BC; and Karleen Habin, MSN, RN, BC-CS


Purpose/Objectives: To describe the experience of women with estrogen receptor–positive breast cancer who are initiating oral adjuvant therapy and to determine what they describe as facilitating and/or hindering this experience.

Research Approach: Qualitative inquiry.

Setting: Massachusetts General Hospital Cancer Center in Boston.

Participants: 14 women aged 48–81 years.

View Article @

ONS Articles

Dive into a rich source of oncology nursing expertise with ONS articles.

View All Articles